FDA Drug Recalls

Recalls / Class I

Class ID-0265-2021

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Sterile Solution, 0.10 fl. oz. (3 ml) each, 25 Applicators in carton, CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co, NDC 54365-400-32 REF 930400

Brand name
Chloraprep One-step
Generic name
Chlorhexidine Gluconate And Isopropyl Alcohol
Active ingredients
Chlorhexidine Gluconate, Isopropyl Alcohol
Route
Topical
NDC
54365-400
FDA application
NDA020832
Affected lot / code info
All lots including but not limited to the following lots distributed in Zone IV: Lot # 0161217 Exp. 05/31/2023; 0211068 Exp. 07/31/2023; 0176660 Exp. 06/30/2023; 0188805 Exp. 06/30/2023; 0175874 Exp. 06/30/2023; 0151977 Exp. 05/31/2023; 0149328 Exp. 04/30/2023; 0085419 Exp. 03/31/2023

Why it was recalled

Non-sterility: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

Recalling firm

Firm
CareFusion 213, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1550 Northwestern Dr, N/A, El Paso, Texas 79912-8000

Distribution

Quantity
988 cartons
Distribution pattern
Distributed in Puerto Rico and Oman

Timeline

Recall initiated
2020-07-07
FDA classified
2021-02-19
Posted by FDA
2021-03-03
Terminated
2022-09-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0265-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.